SCHEMBL30890606

SCHEMBL30890606

CN[C@@H](CC1CC1)C(=O)N1C[C@@]2(C[C@H]1C(N)=O)Oc1cccnc1CNC2=O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 2/20 0.33
▸ OPRM1 P35372 3/20 0.31
▸ OPRK1 P41145 1/20 0.31
▸ CNR2 P34972 4/20 0.31
▸ RECQL P46063 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890574 0.90 NPC1 (0.37) F2OPRM1OPRK1CNR2RECQL
SCHEMBL27245220 0.85 CNR2 (0.30) CNR2
SCHEMBL27245235 0.85 CNR2 (0.30) CNR2
SCHEMBL27244643 0.85 — —
SCHEMBL27244668 0.85 — —
SCHEMBL27245123 0.83 CNR2 (0.30) CNR2
SCHEMBL27245119 0.83 CNR2 (0.30) CNR2
SCHEMBL27245133 0.82 — —
SCHEMBL27245136 0.82 — —
SCHEMBL30890700 0.81 CNR2 (0.32) CNR2RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback